Outstanding Ultrasound clinical images highlight the Esaote's focus in delivering innovative solutions for Interventional Applications, covering all procedures steps: Diagnosys, Planning, Targeting, Assessment and Follow-Up..
The use of contrast agents in the USA is limited by FDA to left ventricle opacification and visualization of the left ventricular endocardial border.
Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. For further details, please contact your Esaote sales representative: email@example.com